Apotex
May 21, 2010 at 13:19 | Source: Reuters
May 20, 2010 at 15:24 | Source: Reuters
Feb 06, 2009 at 16:18
May 05, 2008 at 15:36
Apr 03, 2007 at 16:45
Photos »
/ 
News across the web »
May 19, 2012 at 02:01 | Source: Business Standard
May 18, 2012 at 06:21 | Source: Forbes
May 17, 2012 at 02:41 | Source: Business Standard
Apr 09, 2012 at 22:00 | Source: Business Week
Feb 22, 2012 at 01:41 | Source: Business Standard
Interact & exchange stock tips & market info »
Related News »
Apotex Inc. (Apotex) is one of the leading generic drugmakers in Canada. The company engages in the research, development, manufacture and distribution of generic drugs in Canada and internationally. The company produces around 300 generic drugs in more ...
May 20, 2012 at 01:50 | Source: Transworld News
Law360, New York (May 25, 2012, 8:18 PM ET) -- Allergan Inc. and two Japanese drug makers urged a Delaware federal court Thursday to pause Apotex Inc.'s monopolization suit over Allergan's decision to market a new formulation of Zymar until an underlying ...
May 26, 2012 at 00:17 | Source: site.law360.com
Two dosage forms for the generics were approved: 300 mg, produced by Gate, Mylan, and Teva; and 75 mg, manufactured by Apotex, Aurobindo, Mylan, Roxane, Sun Pharma, Teva, and Torrent. Clopidogrel is approved for secondary prevention of heart ...
May 17, 2012 at 18:50 | Source: MedPage Today
Apotex also marketed a generic version, Apo-Sibutramine, in 2010. Both companies voluntarily withdrew the drug in October 2010 at Health Canada's recommendation, after a study linked sibutramine with increased risk of heart attack and stroke in patients ...
May 23, 2012 at 09:25 | Source: Mondaq
Dr. Bodnar's story hearkens to a time when Plavix's success was in peril. Another drug maker, Apotex, wanted to sell a generic copy of Plavix years before the patent was to expire. Dr. Bodnar, then a senior vice president at Bristol-Myers ...
May 16, 2012 at 04:33 | Source: Wall Street Journal
The FDA said that it had approved 300 mg formulations of clopdiogrel from Gate Pharmaceuticals, Mylan Pharmaceuticals, and Teva Pharmaceuticals and 75 mg formulations from Apotex Corporation, Aurobindo Pharma, Mylan Pharmaceuticals, Roxane ...
May 17, 2012 at 19:05 | Source: Forbes
Canada's Apotex Corp, which won FDA approval to sell clopidogrel at the lower dose, had forfeited its opportunity at six months of generic exclusivity after briefly selling its generic version in 2006 during an ongoing challenge to the Plavix ...
May 17, 2012 at 18:58 | Source: Reuters
According to the FDA, 75-milligram generic Plavix can now be sold by Apotex Corp., Aurobindo Pharma, Mylan Pharmaceuticals, Roxanne Laboratories, Sun Pharma, Teva Pharmaceuticals and Torrent Pharmaceuticals. The larger dose will be sold by Dr ...
May 18, 2012 at 18:49 | Source: CBS News
Shares in Dr Reddy’s on Wednesday closed 0.7 per cent higher at Rs 1,666.95 on the Bombay Stock Exchange. In 2006, Canada’s Apotex launched a generic version of Plavix in the US at a risk being the first to file for a copy and had also earned a right ...
May 16, 2012 at 18:59 | Source: Business Standard
Apart from Mylan, Apotex Corporation, Aurobindo Pharma, Roxane Laboratories, Sun Pharma, Teva Pharmaceuticals (TEVA - Analyst Report) and Torrent Pharmaceuticals gained approval for the 75 mg dosage of clopidogrel. Meanwhile, Dr. Reddy's Laboratories (RDY ...
May 21, 2012 at 16:30 | Source: Zacks.com